Key Highlights

● Clover Health climbed $0.21 to close at $4.79.

● CMS awarded its PPO plans five stars for 2027.

● Contract H-5141 moved up from 4.5 stars.

● The stock gave back part of its early jump.

Clover Health (NASDAQ:CLOV) climbed $0.21 to close at $4.79 on Friday, after trading much higher before the opening bell. The trigger was the 2027 Medicare Advantage Star Ratings released by the Centers for Medicare & Medicaid Services (CMS) on Thursday, October 8. CMS awarded Clover's PPO plans a five-star rating, the highest possible score, with its contract H-5141 moving up from 4.5 stars to 5.

For a Medicare Advantage insurer, a top rating is a major commercial asset. Plans rated four stars or higher qualify for quality Bonus payments from the government, and five-star plans gain extra Marketing flexibility, including the ability to enrol members outside the usual annual window.

How the star system works

CMS scores Medicare Advantage plans each year on a scale of one to five stars, using measures such as preventive care, management of chronic conditions, member experience and customer service. The ratings feed directly into the money insurers receive, which makes the annual release one of the most closely watched events for managed-care stocks.

Clover, which runs PPO plans that give members broad access to doctors, has leaned heavily on its technology platform, designed to help physicians identify and manage chronic disease earlier.

Winners and losers across the sector

The 2027 ratings created a sharp split across health insurers on Friday. Humana (NYSE:HUM) surged after nearly all of its Medicare Advantage members landed in plans rated four stars or higher, and CMS restored its flagship contract to four stars. CVS Health (NYSE:CVS) came under pressure early after its share of members in highly rated plans fell, while Alignment Healthcare (NASDAQ:ALHC) tumbled after its largest contract slipped to 3.5 stars.

Clover's gain fitted into the winners' column, though the stock gave back a good part of its early jump as the session went on. Moves that are large before the open often fade once regular trading Volume arrives and investors weigh the news more carefully.

The wider market

Health care was one of the strongest S&P 500 sectors on Friday, helped by managed care and a biotech rally tied to a report on a planned NIH-linked cancer-vaccine initiative. The S&P 500 rose 46.18 points to 7,811.54, finishing about 7 points below its record close, and the Dow gained 423.31 points to 51,654.95.

Smaller companies trailed. The Russell 2000 added 12.85 points to 2,806.98 but closed out its fifth straight losing week. Small caps have been weighed down by borrowing costs: the 10-year Treasury Yield is near a 24-year high, and the Federal Reserve raised rates in September for the first time since 2023. Fed Governor Christopher Waller said Thursday he anticipates additional hikes to bring Inflation back to the Fed's goal.

The consumer picture is soft as well. The University of Michigan's preliminary sentiment index for October dropped to 46.3, a five-month low, and the survey's director, Joanne Hsu, said: "Frustration over cost-of-living continues to mount". For health insurers serving older Americans, cost pressure on members is a constant theme in plan design and enrolment.

Membership Growth Will Show Whether Five Stars Pays Off

Investors will watch whether Clover can turn its five-star status into membership growth, and how rival insurers respond to their own ratings. On the macro front, September consumer price data comes on Wednesday, October 14, bank Earnings run from October 13 to 16, and the Fed meets on October 27 to 28. Stocks trade on Monday, October 12, while the Bond Market is closed for Columbus Day.